DK200586A - Anvendelse af pyridinonforbindelser med antithrombotisk virkning i laegemidler - Google Patents

Anvendelse af pyridinonforbindelser med antithrombotisk virkning i laegemidler Download PDF

Info

Publication number
DK200586A
DK200586A DK200586A DK200586A DK200586A DK 200586 A DK200586 A DK 200586A DK 200586 A DK200586 A DK 200586A DK 200586 A DK200586 A DK 200586A DK 200586 A DK200586 A DK 200586A
Authority
DK
Denmark
Prior art keywords
antithromobotic
application
effect
medicinal products
pyridinone compounds
Prior art date
Application number
DK200586A
Other languages
Danish (da)
English (en)
Other versions
DK200586D0 (da
Inventor
Juergen Daemmgen
Helmut Ballhause
Walter Haarman
Joachim Heider
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of DK200586D0 publication Critical patent/DK200586D0/da
Publication of DK200586A publication Critical patent/DK200586A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/91Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK200586A 1985-05-03 1986-05-01 Anvendelse af pyridinonforbindelser med antithrombotisk virkning i laegemidler DK200586A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853515882 DE3515882A1 (de) 1985-05-03 1985-05-03 Arzneimittel, enthaltend pyridinone mit antithrombotischen wirkungen und verfahren zu ihrer herstellung
DE3515882 1985-05-03

Publications (2)

Publication Number Publication Date
DK200586D0 DK200586D0 (da) 1986-05-01
DK200586A true DK200586A (da) 1986-11-04

Family

ID=6269707

Family Applications (1)

Application Number Title Priority Date Filing Date
DK200586A DK200586A (da) 1985-05-03 1986-05-01 Anvendelse af pyridinonforbindelser med antithrombotisk virkning i laegemidler

Country Status (6)

Country Link
EP (1) EP0210342A2 (fr)
JP (1) JPS61254524A (fr)
AU (1) AU5706486A (fr)
DE (1) DE3515882A1 (fr)
DK (1) DK200586A (fr)
ZA (1) ZA863304B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3533542B2 (ja) * 1994-03-08 2004-05-31 株式会社大塚製薬工場 ホスホン酸ジエステル誘導体
RU2177317C1 (ru) * 2000-10-24 2001-12-27 Московский научно-исследовательский институт медицинской экологии (МНИИМЭ) Производные хинолина для коррекции системы гемостаза, фармацевтическая композиция, средство для коррекции гемостаза
US6642244B2 (en) 2001-03-16 2003-11-04 Bristol-Myers Squibb Co. Pyrazolopyridopyrimidine inhibitors of cGMP phosphodiesterase
CA2584507C (fr) 2004-10-20 2016-04-26 Resverlogix Corp. Flavanoides et isoflavanoides pour la prevention et le traitement de maladies cardio-vasculaires
CA2676984C (fr) 2007-02-01 2015-03-17 Resverlogix Corp. Composes destines a la prevention et au traitement de maladies cardiovasculaires
CN101531638B (zh) * 2008-03-13 2011-12-28 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
CA2711103C (fr) 2008-06-26 2016-08-09 Resverlogix Corp. Procedes de preparation de derives de quinazolinone
CN101628913B (zh) 2008-07-18 2013-01-23 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
AU2010204106B2 (en) * 2009-01-08 2014-05-08 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
WO2010106436A2 (fr) 2009-03-18 2010-09-23 Resverlogix Corp. Nouveaux agents anti-inflammatoires
AU2010239266B2 (en) 2009-04-22 2015-01-22 Resverlogix Corp. Novel anti-inflammatory agents
CA2851996C (fr) 2011-11-01 2020-01-07 Resverlogix Corp. Compositions pharmaceutiques pour des quinazolinones substituees
WO2014080291A2 (fr) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Dérivés biaryle servant d'inhibiteurs de bromodomaines
WO2014080290A2 (fr) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Amines cycliques servant d'inhibiteurs de bromodomaines
US9271978B2 (en) 2012-12-21 2016-03-01 Zenith Epigenetics Corp. Heterocyclic compounds as bromodomain inhibitors
WO2016147053A1 (fr) 2015-03-13 2016-09-22 Resverlogix Corp. Compositions et procédés thérapeutiques pour le traitement de maladies associées au complément

Also Published As

Publication number Publication date
DE3515882A1 (de) 1986-11-06
EP0210342A2 (fr) 1987-02-04
ZA863304B (en) 1988-01-27
DK200586D0 (da) 1986-05-01
JPS61254524A (ja) 1986-11-12
AU5706486A (en) 1986-11-06

Similar Documents

Publication Publication Date Title
DK200586A (da) Anvendelse af pyridinonforbindelser med antithrombotisk virkning i laegemidler
DK381985D0 (da) 3-pyridylforbindelser, deres fremstilling og anvendelse som laegemiddel
ES551391A0 (es) Un metodo para aumentar la estabilidad termica de la alfa-amilasa bacteriana
DK92786D0 (da) Labdaner, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
DK143284D0 (da) Thiazolinderivater,deres fremstilling og anvendelse som laegemiddel
DK527684D0 (da) 1,5-disubstituerede 1h-pyrazol-4-carboxamidderivater, deres fremstilling og mellemprodukter hertil samt deres anvendelse som herbicider og algicider
NO802563L (no) (+)-catechin-salter, deres fremstilling og anvendelse, og blandinger som inneholder disse salter
DK298984D0 (da) Tetrahydropyridazinoner eller syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter og disses fremstilling
DK219685D0 (da) Heterocycliske forbindelser, deres fremstilling og anvendelse som laegemidler
DK170986D0 (da) Substituerede 2,3,4,9-tetrahydro-1h-carbazol-1-eddikesyre-derivater, deres fremstilling og anvendelse som farmaceutika samt mellemprodukterved fremstillingen
DK1590A (da) Protease-deficiente gram-positive bakterier og deres anvendelse som vaertsorganismer til produktion af rekombinante produkter
DK123786D0 (da) 4-(3-carboxy-3-diazo-2-oxopropyl)-azetidin-2-oner, deres fremstilling og anvendelse som carbapenemantibiotikummellemprodukter
DK165005C (da) Analogifremgangsmaade til fremstilling af 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater eller terapeutisk acceptable salte deraf
DK284688D0 (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler
DK55386A (da) Anlaeg til fremstilling af sodavands- og floedeis, som er forsynet med holdepind
DK614186A (da) Substituerede piperazin-1,4-naphtalendioner, deres fremstilling og anvendelse som laegemidler
DK627684A (da) 1,4-naphthoquinolinderivater, deres fremstilling og anvendelse som laegemiddel
DK163816C (da) 1,4-dihalogenbutan-2,3-dioner til brug som mellemprodukter ved fremstillingen af 2-(2-aminothiazol-4-yl)glyoxylsyrederivater eller salte heraf og fremgangsmaade til fremstilling af mellemprodukterne
DK562686A (da) 2,2 -bi-1h-imidazoler, tautomere og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse som cardiotonika samt mellemprodukter ved fremstillingen
DK413485D0 (da) Phenoxypropionsyre-derivater, deres fremstilling og anvendelse som herbicider, samt ved fremstillingen anvendelige mellemprodukter og fremstilling heraf
DK88985A (da) Aminodiarylsulfoxidderivater og syreadditionssalte deraf, deres anvendelse som farmaceutika og pesticider
DK10685D0 (da) Sulfonylguanidinderivater, deres fremstilling og anvendelse som herbicider
SE7613536L (sv) Sett att framstella 3,4-disubstituerade 2-(beta-naftyl-oxi)-etylpyrazoloner och anvendning derav som lekemedel
DK0401125T3 (da) Biphenylderivater, fremgangsmåde til fremstilling af disse samt mellemprodukter derfor
DK118486D0 (da) Isoxazolidiner, deres fremstilling og anvendelse som midler til bekaempelse af skadelige organismer, samt ved fremstillingen anvendelige mellemprodukter og fremstilling heraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment